Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/1d526e74-f6a7-4a31-8bbc-6b896e2d2d06/

DH

Definitive Healthcare Corp
Chart
0.76 USD
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.6w · Fresh
0.76
OS Score
88.0%
Value
73.0%
Quality
0.0%
Momentum
#99.00000000
TV Rank
5/9
F-Score
0.801
QV
Strategy Eligibility
7 of 23 passing
OS Composite
Trending Value
Quality × Value
QV 0.801
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
VC2 5
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
39.3%
💰
High Yield
Div 3.9%
🚀
Momentum Leaders
Market Leaders
Tiny Titans
Yes
🔍
Small Cap Value
Val 88%
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
CAQ 0.62
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
88.0%ile
P/S
0.3×
P/B
0.5×
FCF Yield
0.416
SH Yield
0.393
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
8.00000000
/100 — 1=cheapest
VC2 (Trending Value)
5.00000000
/100
VC3 (Buyback)
5.00000000
/100
FCF yield of 41.6% is strong — the business generates significant free cash relative to price. VC2 score of 5.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
73.0%ile
ROE
-1.165
ROA
-0.331
Net Margin
-0.715
Op Margin
-0.955
GPA
0.336
D/E
2.22
Current
1.66
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.039
Stability
0.881
lower=better
Accruals
-0.407
lower=better
5yr Consist
No
Highly leveraged with D/E of 2.22 — returns are being amplified by debt.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
0.0%ile
6M Return
-68.2%
12M Return
-80.2%
12-1 Mom
-80.2%
Risk-Adj
-1.38
Vol 252d
58.0%
Vol 60d
134.6%
↑ Expanding
Max DD 12M
-84.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -80% signals a downtrend — price is moving against you. Near-term vol (135%) is expanding vs long-term (58%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.76
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
92.8%
Sector Quality %ile
80.4%
P/B z-score
-0.30
Sector Avg OS
64.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 91.0% 98.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 96.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 90.0% 93.0% 93.0%
NUTX Nutex Health Inc 98.0% 91.0% 98.0% 80.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 84.0%
CGEN Compugen 98.0% 89.0% 96.0% 82.0%
FBIO Fortress Biotech Inc 98.0% 98.0% 84.0% 88.0%
MD Mednax Inc 97.0% 85.0% 84.0% 93.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (88th) and quality (73th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Falling Knife
Weak momentum (0th) despite looking cheap (88th value). Wait for momentum to stabilise.
Strong Capital Return
Shareholder yield 39.3% backed by 41.6% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (135%) significantly exceeds 252-day (58%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
99.8% avg (4 factors)
Quality
D
32.3% avg (8 factors)
Momentum
F
0.0% avg (4 factors)
Risk
F
20.0% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.760—7
Value %ile0.880—7
Quality %ile0.730—4
Momentum %ile0.000—7
F-Score5.000—0
Confidence0.822—7
Volatility0.580—7
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
0.34
Price / Book
0.55
Price / Cash Flow
2.04
FCF Yield
41.6%
Sales Yield (1/P·S)
1.7423
Shareholder Yield
Div + net buyback / mktcap
39.3%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-116.5%
Return on Assets
-33.1%
Net Margin
-71.5%
Operating Margin
-95.5%
Gross Profit / Assets
Novy-Marx GPA
33.6%
Debt / Equity
2.22
Current Ratio
1.66
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.407
MomentumPrice trend strength over different horizons
6M Return
-68.2%
12M Return
-80.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-80.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-1.38
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-3.9%
Earnings Stability (CV)
Lower = more stable
0.881
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
3.9%
Buyback Yield
35.3%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
8
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
5
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
5
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
99
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity